Jump to content

Olecumab Plus Osimertinib (Tagrisso) Trial for EGFR+ NSCLC


Judy M2

Recommended Posts

Someone just posted the article below on the LUNGevity FB EGFR Resisters Group page regarding a promising trial for a combo treatment after progression on Tagrisso. 

https://www.targetedonc.com/view/oleclumab-plus-osimertinib-show-early-activity-and-tolerability-egfr-mutant-nsclc

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.